Home > Insider Trading > Krystal Biotech Inc.

Krystal Biotech Inc. (KRYS)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Krystal Biotech, Inc. (NASDAQ:KRYS) Q3 2024 Earnings Call Transcript

Operator: Thank you for standing by and welcome to Krystal Biotech's Third Quarter Earnings Conference Call. [Operator Instructions] As a reminder, today's conference is being recorded.

Keep Reading →

November 5th, 2024 - News Transcripts

10 Worst Booming Stocks to Buy According to Short Sellers

September has historically been one of the worst months for US stocks.

Keep Reading →

September 14th, 2024 - Hedge Funds News

Krystal Biotech (KRYS) Surged as it Beat the Streat Estimates with Wide Margin

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” first-quarter 2024 investor letter.

Keep Reading →

June 21st, 2024 - Hedge Fund Investor Letters News

Is Krystal Biotech, Inc. (NASDAQ:KRYS) the Premier Gene Therapy Stock for Your Portfolio?

We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Krystal Biotech, Inc.

Keep Reading →

June 3rd, 2024 - Hedge Funds News

9 Best Gene Therapy Stocks to Buy Now

In this article, we will be discussing the best gene therapy stocks to buy now. Before we move on to our list, let's take a look at the market outlook for gene therapies and understand the reasons behind...

Keep Reading →

June 3rd, 2024 - Hedge Funds News Stock Analysis

Krystal Biotech, Inc. (NASDAQ:KRYS) Q1 2024 Earnings Call Transcript

Krystal Biotech, Inc. misses on earnings expectations. Reported EPS is $0.03182 EPS, expectations were $0.2. Krystal Biotech, Inc.

Keep Reading →

May 7th, 2024 - News Transcripts

Krystal Biotech, Inc. (NASDAQ:KRYS) Q4 2023 Earnings Call Transcript

Operator: Thank you for standing by and welcome to the Krystal Biotech Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time, all participants are on a lesson-only mode.

Keep Reading →

February 28th, 2024 - News Transcripts

12 Best Genomics Stocks To Buy Now

In this piece, we will take a look at the 12 best genomics stocks to buy now.

Keep Reading →

December 10th, 2023 - Hedge Funds News

Here’s Why TimesSquare Capital Management U.S. Small Cap Growth Strategy Added Krystal Biotech (KRYS)

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” third-quarter investor letter. A copy of the same can be downloaded here.

Keep Reading →

December 7th, 2023 - Hedge Fund Investor Letters News

Krystal Biotech, Inc. (NASDAQ:KRYS) Q3 2023 Earnings Call Transcript

Operator: Thank you for standing by and welcome to the Krystal Biotech Third Quarter 2023 Earnings Conference Call. As a reminder today’s conference call is being recorded.

Keep Reading →

November 7th, 2023 - News Transcripts